Skin Cancer

>

Latest News

Leveraging Molecular Diagnostics for Tailored Skin Cancer Care
Leveraging Molecular Diagnostics for Tailored Skin Cancer Care

July 25th 2025

Discover how gene expression profiling transforms melanoma and SCC management, enhancing personalized treatment strategies and improving patient outcomes in skin cancer care.

Castle Biosciences’ DecisionDx-Melanoma Test Earns FDA Breakthrough Device Designation
Castle Biosciences’ DecisionDx-Melanoma Test Earns FDA Breakthrough Device Designation

July 23rd 2025

FDA Issues CRL for RP1 and Nivolumab in Melanoma
FDA Issues CRL for RP1 and Nivolumab in Melanoma

July 22nd 2025

Journal Digest: July 16, 2025
Journal Digest: July 16, 2025

July 16th 2025

How GEP Testing is Personalizing Skin Cancer Care Beyond Staging
How GEP Testing is Personalizing Skin Cancer Care Beyond Staging

July 11th 2025

Latest CME Events & Activities

More News

© 2025 MJH Life Sciences

All rights reserved.